The study aimed to estimate the prevalence and direct costs of neuromyelitis optica (NMO) patients in Campania, Italy. Materials & methods: We retrospectively evaluated 53 NMO patients (mean age: 50.9 ± 16.5 years; 34% men) from the Campania Region administrative databases identified through disease exemption codes in 2018 and analyzed the incidence of NMO among the Campania region population and the disease-related cost. Results: The prevalence of NMO was 0.91 per 100,000 individuals. The average regional cost per NMO patient was 10,836.2 euros. The highest cost was related to drugs (60.6%), followed by hospitalizations (32.7%), diagnostics (4.8%) and laboratory tests (1.0%). Conclusion: NMO is an extremely rare disease with an annual disease-related cost of 0.005% of public health expenditure

Monda, E., Iucolano, S., Galdo, M., Bernardi, F.f., Chiodini, P., D'Angela, D., et al. (2021). Prevalence and direct costs of patients with neuromyelitis optica: data from Campania region in southern Italy. FUTURE RARE DISEASES, 1(4) [10.2217/frd-2021-0011].

Prevalence and direct costs of patients with neuromyelitis optica: data from Campania region in southern Italy

Di Gennaro M.;Spandonaro F.;
2021-12-01

Abstract

The study aimed to estimate the prevalence and direct costs of neuromyelitis optica (NMO) patients in Campania, Italy. Materials & methods: We retrospectively evaluated 53 NMO patients (mean age: 50.9 ± 16.5 years; 34% men) from the Campania Region administrative databases identified through disease exemption codes in 2018 and analyzed the incidence of NMO among the Campania region population and the disease-related cost. Results: The prevalence of NMO was 0.91 per 100,000 individuals. The average regional cost per NMO patient was 10,836.2 euros. The highest cost was related to drugs (60.6%), followed by hospitalizations (32.7%), diagnostics (4.8%) and laboratory tests (1.0%). Conclusion: NMO is an extremely rare disease with an annual disease-related cost of 0.005% of public health expenditure
dic-2021
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore SECS-P/06 - ECONOMIA APPLICATA
English
Campania region • costs of illness • epidemiology • Italy • neuromyelitis optica
https://www.futuremedicine.com/doi/full/10.2217/frd-2021-0011
Monda, E., Iucolano, S., Galdo, M., Bernardi, F.f., Chiodini, P., D'Angela, D., et al. (2021). Prevalence and direct costs of patients with neuromyelitis optica: data from Campania region in southern Italy. FUTURE RARE DISEASES, 1(4) [10.2217/frd-2021-0011].
Monda, E; Iucolano, S; Galdo, M; Bernardi, Ff; Chiodini, P; D'Angela, D; Giordana, R; Di Gennaro, M; Trama, U; Spandonaro, F; Limongelli, G; Polistena...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
2021 frd.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 204.31 kB
Formato Adobe PDF
204.31 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/287477
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact